Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China

Science of the Total Environment

Volumn 408, Issue 16, 2010, Pages 3139-3147

  Wang, Li ^a   Ying, Guang Guo ^a   Zhao, Jian Liang ^a   Yang, Xiao Bing ^a   Chen, Feng ^a   Tao, Ran ^a   Liu, Shan ^a   Zhou, Li Jun ^a  

^a GUANGZHOU INSTITUTE OF GEOCHEMISTRY   (China)

Author keywords

Hai River; Liao River; Pharmaceuticals; Risk assessment; Yellow River

Indexed keywords

ACIDIC COMPOUNDS; ACIDIC PHARMACEUTICALS; AQUATIC ENVIRONMENTS; AQUATIC ORGANISMS; CLOFIBRIC ACID; DICLOFENAC; DRY SEASONS; GEMFIBROZILS; HAI RIVER; HIGH CONCENTRATION; HUMAN HEALTH; INDOMETHACIN; KETOPROFEN; LIAO RIVER; LIPID REGULATORS; MEFENAMIC ACID; METROPOLITAN AREA; NAPROXENS; NON-STEROIDAL ANTI-INFLAMMATORY DRUGS; NORTH CHINA; POTENTIAL IMPACTS; POTENTIAL RISKS; RIVER CONFLUENCE; SALICYLIC ACIDS; SCIENTIFIC COMMUNITY; TOLFENAMIC ACID; WET AND DRY SEASONS; WET SEASON; YELLOW RIVER;

ACIDS; AQUACULTURE; DROUGHT; DRUG PRODUCTS; HEALTH RISKS; HERBICIDES; RISK ASSESSMENT; RISK MANAGEMENT;

RIVERS;

CLOFIBRIC ACID; DICLOFENAC; FENOPROFEN; GEMFIBROZIL; IBUPROFEN; INDOMETACIN; KETOPROFEN; MECLOFENAMIC ACID; MEFENAMIC ACID; NAPROXEN; SALICYLIC ACID; SURFACE WATER; TOLFENAMIC ACID; DRUG; FRESH WATER; WATER POLLUTANT;

CONCENTRATION (COMPOSITION); DRUG; HEALTH RISK; HERBICIDE; RISK ASSESSMENT; SURFACE WATER; WATER POLLUTION;

ACIDITY; AQUATIC SPECIES; ARTICLE; CHEMICAL ANALYSIS; CHINA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENVIRONMENTAL IMPACT; GEOGRAPHIC DISTRIBUTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEASONAL VARIATION; STREAM (RIVER); WATER ANALYSIS; ANALYSIS; WATER POLLUTANT;

CHINA; FRESH WATER; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL;

CHINA; HAI RIVER; LIAOHE RIVER; YELLOW RIVER;

EID: 77953721394     PISSN: 00489697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2010.04.047     Document Type: Article

References (40)

1. Ashton D., Hilton M., Thomas K.V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 2004, 333:167-184.
2. Carlsson C., Johansson A.K., Alvan G., Bergman K., Kühler T. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients. Sci Total Environ 2006, 364:67-87.
3. Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 2003, 142:185-194.
4. Cleuvers M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen and acetylsalicyclic acid. Ecotoxicol Environ Saf 2004, 59:309-315.
5. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspec 1999, 107:907-938.
6. Technical Guidance Document in Support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances and Commission Regulation (EC) No 1488/94 on Risk Assessment for Existing Substances, Part II. Brussels, Belgium 2003, European Commission.
7. European agency for the evaluation of medicinal products Committee for medicinal products for human use (CHMP). Guideline on the environmental riskassessment of medicinal products for human use. Ref EMEA/CRMP/SWP/4447/00. London, UK 2006.
8. Farré M.L., Ferrer I., Ginebreda A., Figueras M., Olivella L., Tirapu L., et al. Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. J Chromatogr A 2001, 938:187-197.
9. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 2006, 76:122-159.
10. Fernández C., González-Doncel M., Pro J., Carbonell G., Tarazona J.V. Occurrence of pharmaceutically active compounds in surface waters of the henares-jarama-tajo river system (Madrid, Spain) and a potential risk characterization. Sci Total Environ 2010, 408:543-551.
11. Focazio M.J., Kolpin D.W., Barnes K.K., Furlong E.T., Meyer M.T., Zaugg S.D., et al. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States - II) untreated drinking water sources. Sci Total Environ 2008, 402:201-216.
12. Gros M., Petrovió M., Barceló D. Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro River basin (northeast Spain). Environ Toxicol Chem 2007, 26:1553-1562.
13. Grung M., Källqvist T., Sakshaug S., Skurtveit S., Thomas K.V. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicol Environ Saf 2008, 71:328-340.
14. Halling-Sørensen B., Nors Nilesen S., Lanzky P.F., Ingerslev F., Holten Lützhøft H.C., Jørgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36:357-393.
15. Hernando M.D., Mezcua M., Fernández-Alba A.R., Barceló D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69:334-342.
16. Isidori M., Lavorgna M., Nardelli A. Toxic and genotoxic evaluation of six antibiotics on non-target organisms. Sci Total Environ 2005, 346:87-98.
17. Kasprzyk-Hordern B., Dinsdale R.M., Guwy A.J. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res 2008, 42:3498-3518.
18. Kim S.D., Cho J., Kim I.S., Vanderford B.J., Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res 2007, 41:1013-1021.
19. Kümmerer K. The presence of pharmaceuticals in the environment due to human use - present knowledge and future challenges. J Environ Manage 2009, 90:2354-2366.
20. Li Z.Q., Li B.W., Li L.P. Suggestion on the pollution control of Liao River system. Water Resour Hydropower Northeast China Chin 2000, 18:3-4.
21. Metcalfe C.D., Miao X.S., Koenig B.G., Struger J. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ Toxicol Chem 2003, 22:2881-2889.
22. Miao X.S., Koenig B.G., Metcalfe C.D. Analysis of acidic drugs in the effluents of sewage treatment plants using liquid chromatography-electrospray ionization tandem mass spectrometry. J Chromatogr A 2002, 952:139-147.
23. Nakada N., Tanishima T., Shinohara H., Kiri K., Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res 2006, 40:3297-3303.
24. Nebot C., Gibb S.W., Boyd K.G. Quantification of human pharmaceuticals in water samples by high performance liquid chromatography-tandem mass spectrometry. Anal Chim Acta 2007, 598:87-94.
25. Quinn B., Gagné F., Blaise C. An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuate. Sci Total Environ 2008, 389:306-314.
26. Roefer P., Snyder S.A., Zegers R.E., Rexing D.J., Fronk J.L. Endocrine-disrupting chemicals in a source water. J AWWA 2000, 92:52-58.
27. Santos J.L., Aparicio I., Alonso E. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ Int 2007, 33:596-601.
28. Stuer-Lauridsen F., Birkved M., Hansen L.P., Halling-Sørensen B., Holten Lützhøft H.C. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 2000, 40:783-793.
29. Stumpf M., Ternes T.A., Wilken R.D., Rodrigues S.V., Baumann W. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 1999, 225:135-141.
30. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., Tarradellas J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res 2005, 39:1761-1772.
31. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998, 32:3245-3260.
32. Tixier C., Singer H.P., Oellers S., Müller S.R. Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters. Environ Sci Technol 2003, 37:1061-1068.
33. Trussell R.R. Endocrine disruptors and the water industry. J AWWA 2001, 93:58-65.
34. Vieno N.M., Tuhkanen T., Kronberg L. Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ Sci Technol 2005, 39:8220-8226.
35. Xu J., Wang P., Guo W.F., Dong J.X., Wang L., Dai S.G. Seasonal and spatial distribution of nonylphenol in Lanzhou Reach of Yellow River in China. Chemosphere 2006, 65:1445-1451.
36. Yang L.H., Ying G.G., Su H.C., Stauber J.L., Adams M.S., Binet M.T. Growth-inhibiting effects of 12 antimicrobial agents and their mixtures on the freshwater microalga Pseudokirchneriella subcapitata. Environ Toxicol Chem 2008, 27:1201-1208.
37. Ying G.G., Kookana R.S., Kolpin D.W. Occurrence and removal of pharmaceutically active compounds in sewage treatment plants with different technologies. J Environ Monit 2009, 11:1498-1505.
38. Zhang S.Y., Zhang Q., Darisaw S., Ehie O., Wang G.D. Simultaneous quantification of polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and pharmaceuticals and personal care products (PPCPs) in Mississippi river water, in New Orleans, Louisiana, USA. Chemosphere 2007, 66:1057-1069.
39. Zhao JL, Ying GG, Liu YS, Chen F, Yang JF, Wang L, et al. Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, south China. Environ Toxicol Chem 2010, 10.1002/etc.161.
40. Zhao J.L., Ying G.G., Wang L., Yang J.F., Yang X.B., Yang L.H., et al. Determination of phenolic endocrine disrupting chemicals and acidic pharmaceuticals in surface water of the Pearl Rivers in South China by gas chromatography-negative chemical ionization-mass spectrometry. Sci Total Environ 2009, 407:962-974.